Global Influenza Diagnostics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 268575
  • calendar_today Published On: Jan, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Influenza Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Influenza Diagnostics market size is estimated to be worth US$ 2403.1 million in 2021 and is forecast to a readjusted size of USD 3620.3 million by 2028 with a CAGR of 6.0% during review period. Hospitals accounting for % of the Influenza Diagnostics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While RIDT segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Influenza Diagnostics include BD, Abbott (Include Alere), Roche, SIEMENS, and Analytik Jena, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Influenza Diagnostics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

RIDT

RT-PCR

Cell Culture

Others

Market segment by Application, can be divided into

Hospitals

POCT

Others

Market segment by players, this report covers

BD

Abbott (Include Alere)

Roche

SIEMENS

Analytik Jena

Quidel

Thermo Fisher

Meridian Bioscience

BioMerieux

Sekisui Diagnostics

Response Biomedical

SA Scientific

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Influenza Diagnostics product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Influenza Diagnostics, with revenue, gross margin and global market share of Influenza Diagnostics from 2019 to 2022.

Chapter 3, the Influenza Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Influenza Diagnostics market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Influenza Diagnostics research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Influenza Diagnostics

1.2 Classification of Influenza Diagnostics by Type

1.2.1 Overview: Global Influenza Diagnostics Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Influenza Diagnostics Revenue Market Share by Type in 2021

1.2.3 RIDT

1.2.4 RT-PCR

1.2.5 Cell Culture

1.2.6 Others

1.3 Global Influenza Diagnostics Market by Application

1.3.1 Overview: Global Influenza Diagnostics Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 POCT

1.3.4 Others

1.4 Global Influenza Diagnostics Market Size & Forecast

1.5 Global Influenza Diagnostics Market Size and Forecast by Region

1.5.1 Global Influenza Diagnostics Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Influenza Diagnostics Market Size by Region, (2017-2022)

1.5.3 North America Influenza Diagnostics Market Size and Prospect (2017-2028)

1.5.4 Europe Influenza Diagnostics Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Influenza Diagnostics Market Size and Prospect (2017-2028)

1.5.6 South America Influenza Diagnostics Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Influenza Diagnostics Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Influenza Diagnostics Market Drivers

1.6.2 Influenza Diagnostics Market Restraints

1.6.3 Influenza Diagnostics Trends Analysis

2 Company Profiles

2.1 BD

2.1.1 BD Details

2.1.2 BD Major Business

2.1.3 BD Influenza Diagnostics Product and Solutions

2.1.4 BD Influenza Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 BD Recent Developments and Future Plans

2.2 Abbott (Include Alere)

2.2.1 Abbott (Include Alere) Details

2.2.2 Abbott (Include Alere) Major Business

2.2.3 Abbott (Include Alere) Influenza Diagnostics Product and Solutions

2.2.4 Abbott (Include Alere) Influenza Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Abbott (Include Alere) Recent Developments and Future Plans

2.3 Roche

2.3.1 Roche Details

2.3.2 Roche Major Business

2.3.3 Roche Influenza Diagnostics Product and Solutions

2.3.4 Roche Influenza Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Roche Recent Developments and Future Plans

2.4 SIEMENS

2.4.1 SIEMENS Details

2.4.2 SIEMENS Major Business

2.4.3 SIEMENS Influenza Diagnostics Product and Solutions

2.4.4 SIEMENS Influenza Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 SIEMENS Recent Developments and Future Plans

2.5 Analytik Jena

2.5.1 Analytik Jena Details

2.5.2 Analytik Jena Major Business

2.5.3 Analytik Jena Influenza Diagnostics Product and Solutions

2.5.4 Analytik Jena Influenza Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Analytik Jena Recent Developments and Future Plans

2.6 Quidel

2.6.1 Quidel Details

2.6.2 Quidel Major Business

2.6.3 Quidel Influenza Diagnostics Product and Solutions

2.6.4 Quidel Influenza Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Quidel Recent Developments and Future Plans

2.7 Thermo Fisher

2.7.1 Thermo Fisher Details

2.7.2 Thermo Fisher Major Business

2.7.3 Thermo Fisher Influenza Diagnostics Product and Solutions

2.7.4 Thermo Fisher Influenza Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Thermo Fisher Recent Developments and Future Plans

2.8 Meridian Bioscience

2.8.1 Meridian Bioscience Details

2.8.2 Meridian Bioscience Major Business

2.8.3 Meridian Bioscience Influenza Diagnostics Product and Solutions

2.8.4 Meridian Bioscience Influenza Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Meridian Bioscience Recent Developments and Future Plans

2.9 BioMerieux

2.9.1 BioMerieux Details

2.9.2 BioMerieux Major Business

2.9.3 BioMerieux Influenza Diagnostics Product and Solutions

2.9.4 BioMerieux Influenza Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 BioMerieux Recent Developments and Future Plans

2.10 Sekisui Diagnostics

2.10.1 Sekisui Diagnostics Details

2.10.2 Sekisui Diagnostics Major Business

2.10.3 Sekisui Diagnostics Influenza Diagnostics Product and Solutions

2.10.4 Sekisui Diagnostics Influenza Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Sekisui Diagnostics Recent Developments and Future Plans

2.11 Response Biomedical

2.11.1 Response Biomedical Details

2.11.2 Response Biomedical Major Business

2.11.3 Response Biomedical Influenza Diagnostics Product and Solutions

2.11.4 Response Biomedical Influenza Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Response Biomedical Recent Developments and Future Plans

2.12 SA Scientific

2.12.1 SA Scientific Details

2.12.2 SA Scientific Major Business

2.12.3 SA Scientific Influenza Diagnostics Product and Solutions

2.12.4 SA Scientific Influenza Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 SA Scientific Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Influenza Diagnostics Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Influenza Diagnostics Players Market Share in 2021

3.2.2 Top 10 Influenza Diagnostics Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Influenza Diagnostics Players Head Office, Products and Services Provided

3.4 Influenza Diagnostics Mergers & Acquisitions

3.5 Influenza Diagnostics New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Influenza Diagnostics Revenue and Market Share by Type (2017-2022)

4.2 Global Influenza Diagnostics Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Influenza Diagnostics Revenue Market Share by Application (2017-2022)

5.2 Global Influenza Diagnostics Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Influenza Diagnostics Revenue by Type (2017-2028)

6.2 North America Influenza Diagnostics Revenue by Application (2017-2028)

6.3 North America Influenza Diagnostics Market Size by Country

6.3.1 North America Influenza Diagnostics Revenue by Country (2017-2028)

6.3.2 United States Influenza Diagnostics Market Size and Forecast (2017-2028)

6.3.3 Canada Influenza Diagnostics Market Size and Forecast (2017-2028)

6.3.4 Mexico Influenza Diagnostics Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Influenza Diagnostics Revenue by Type (2017-2028)

7.2 Europe Influenza Diagnostics Revenue by Application (2017-2028)

7.3 Europe Influenza Diagnostics Market Size by Country

7.3.1 Europe Influenza Diagnostics Revenue by Country (2017-2028)

7.3.2 Germany Influenza Diagnostics Market Size and Forecast (2017-2028)

7.3.3 France Influenza Diagnostics Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Influenza Diagnostics Market Size and Forecast (2017-2028)

7.3.5 Russia Influenza Diagnostics Market Size and Forecast (2017-2028)

7.3.6 Italy Influenza Diagnostics Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Influenza Diagnostics Revenue by Type (2017-2028)

8.2 Asia-Pacific Influenza Diagnostics Revenue by Application (2017-2028)

8.3 Asia-Pacific Influenza Diagnostics Market Size by Region

8.3.1 Asia-Pacific Influenza Diagnostics Revenue by Region (2017-2028)

8.3.2 China Influenza Diagnostics Market Size and Forecast (2017-2028)

8.3.3 Japan Influenza Diagnostics Market Size and Forecast (2017-2028)

8.3.4 South Korea Influenza Diagnostics Market Size and Forecast (2017-2028)

8.3.5 India Influenza Diagnostics Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Influenza Diagnostics Market Size and Forecast (2017-2028)

8.3.7 Australia Influenza Diagnostics Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Influenza Diagnostics Revenue by Type (2017-2028)

9.2 South America Influenza Diagnostics Revenue by Application (2017-2028)

9.3 South America Influenza Diagnostics Market Size by Country

9.3.1 South America Influenza Diagnostics Revenue by Country (2017-2028)

9.3.2 Brazil Influenza Diagnostics Market Size and Forecast (2017-2028)

9.3.3 Argentina Influenza Diagnostics Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Influenza Diagnostics Revenue by Type (2017-2028)

10.2 Middle East & Africa Influenza Diagnostics Revenue by Application (2017-2028)

10.3 Middle East & Africa Influenza Diagnostics Market Size by Country

10.3.1 Middle East & Africa Influenza Diagnostics Revenue by Country (2017-2028)

10.3.2 Turkey Influenza Diagnostics Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Influenza Diagnostics Market Size and Forecast (2017-2028)

10.3.4 UAE Influenza Diagnostics Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Influenza Diagnostics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Influenza Diagnostics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Influenza Diagnostics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Influenza Diagnostics Revenue (USD Million) by Region (2017-2022)

Table 5. Global Influenza Diagnostics Revenue Market Share by Region (2023-2028)

Table 6. BD Corporate Information, Head Office, and Major Competitors

Table 7. BD Major Business

Table 8. BD Influenza Diagnostics Product and Solutions

Table 9. BD Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Abbott (Include Alere) Corporate Information, Head Office, and Major Competitors

Table 11. Abbott (Include Alere) Major Business

Table 12. Abbott (Include Alere) Influenza Diagnostics Product and Solutions

Table 13. Abbott (Include Alere) Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Roche Corporate Information, Head Office, and Major Competitors

Table 15. Roche Major Business

Table 16. Roche Influenza Diagnostics Product and Solutions

Table 17. Roche Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. SIEMENS Corporate Information, Head Office, and Major Competitors

Table 19. SIEMENS Major Business

Table 20. SIEMENS Influenza Diagnostics Product and Solutions

Table 21. SIEMENS Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Analytik Jena Corporate Information, Head Office, and Major Competitors

Table 23. Analytik Jena Major Business

Table 24. Analytik Jena Influenza Diagnostics Product and Solutions

Table 25. Analytik Jena Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Quidel Corporate Information, Head Office, and Major Competitors

Table 27. Quidel Major Business

Table 28. Quidel Influenza Diagnostics Product and Solutions

Table 29. Quidel Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Thermo Fisher Corporate Information, Head Office, and Major Competitors

Table 31. Thermo Fisher Major Business

Table 32. Thermo Fisher Influenza Diagnostics Product and Solutions

Table 33. Thermo Fisher Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Meridian Bioscience Corporate Information, Head Office, and Major Competitors

Table 35. Meridian Bioscience Major Business

Table 36. Meridian Bioscience Influenza Diagnostics Product and Solutions

Table 37. Meridian Bioscience Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. BioMerieux Corporate Information, Head Office, and Major Competitors

Table 39. BioMerieux Major Business

Table 40. BioMerieux Influenza Diagnostics Product and Solutions

Table 41. BioMerieux Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Sekisui Diagnostics Corporate Information, Head Office, and Major Competitors

Table 43. Sekisui Diagnostics Major Business

Table 44. Sekisui Diagnostics Influenza Diagnostics Product and Solutions

Table 45. Sekisui Diagnostics Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Response Biomedical Corporate Information, Head Office, and Major Competitors

Table 47. Response Biomedical Major Business

Table 48. Response Biomedical Influenza Diagnostics Product and Solutions

Table 49. Response Biomedical Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. SA Scientific Corporate Information, Head Office, and Major Competitors

Table 51. SA Scientific Major Business

Table 52. SA Scientific Influenza Diagnostics Product and Solutions

Table 53. SA Scientific Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Global Influenza Diagnostics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 55. Global Influenza Diagnostics Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 56. Breakdown of Influenza Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 57. Influenza Diagnostics Players Head Office, Products and Services Provided

Table 58. Influenza Diagnostics Mergers & Acquisitions in the Past Five Years

Table 59. Influenza Diagnostics New Entrants and Expansion Plans

Table 60. Global Influenza Diagnostics Revenue (USD Million) by Type (2017-2022)

Table 61. Global Influenza Diagnostics Revenue Share by Type (2017-2022)

Table 62. Global Influenza Diagnostics Revenue Forecast by Type (2023-2028)

Table 63. Global Influenza Diagnostics Revenue by Application (2017-2022)

Table 64. Global Influenza Diagnostics Revenue Forecast by Application (2023-2028)

Table 65. North America Influenza Diagnostics Revenue by Type (2017-2022) & (USD Million)

Table 66. North America Influenza Diagnostics Revenue by Type (2023-2028) & (USD Million)

Table 67. North America Influenza Diagnostics Revenue by Application (2017-2022) & (USD Million)

Table 68. North America Influenza Diagnostics Revenue by Application (2023-2028) & (USD Million)

Table 69. North America Influenza Diagnostics Revenue by Country (2017-2022) & (USD Million)

Table 70. North America Influenza Diagnostics Revenue by Country (2023-2028) & (USD Million)

Table 71. Europe Influenza Diagnostics Revenue by Type (2017-2022) & (USD Million)

Table 72. Europe Influenza Diagnostics Revenue by Type (2023-2028) & (USD Million)

Table 73. Europe Influenza Diagnostics Revenue by Application (2017-2022) & (USD Million)

Table 74. Europe Influenza Diagnostics Revenue by Application (2023-2028) & (USD Million)

Table 75. Europe Influenza Diagnostics Revenue by Country (2017-2022) & (USD Million)

Table 76. Europe Influenza Diagnostics Revenue by Country (2023-2028) & (USD Million)

Table 77. Asia-Pacific Influenza Diagnostics Revenue by Type (2017-2022) & (USD Million)

Table 78. Asia-Pacific Influenza Diagnostics Revenue by Type (2023-2028) & (USD Million)

Table 79. Asia-Pacific Influenza Diagnostics Revenue by Application (2017-2022) & (USD Million)

Table 80. Asia-Pacific Influenza Diagnostics Revenue by Application (2023-2028) & (USD Million)

Table 81. Asia-Pacific Influenza Diagnostics Revenue by Region (2017-2022) & (USD Million)

Table 82. Asia-Pacific Influenza Diagnostics Revenue by Region (2023-2028) & (USD Million)

Table 83. South America Influenza Diagnostics Revenue by Type (2017-2022) & (USD Million)

Table 84. South America Influenza Diagnostics Revenue by Type (2023-2028) & (USD Million)

Table 85. South America Influenza Diagnostics Revenue by Application (2017-2022) & (USD Million)

Table 86. South America Influenza Diagnostics Revenue by Application (2023-2028) & (USD Million)

Table 87. South America Influenza Diagnostics Revenue by Country (2017-2022) & (USD Million)

Table 88. South America Influenza Diagnostics Revenue by Country (2023-2028) & (USD Million)

Table 89. Middle East & Africa Influenza Diagnostics Revenue by Type (2017-2022) & (USD Million)

Table 90. Middle East & Africa Influenza Diagnostics Revenue by Type (2023-2028) & (USD Million)

Table 91. Middle East & Africa Influenza Diagnostics Revenue by Application (2017-2022) & (USD Million)

Table 92. Middle East & Africa Influenza Diagnostics Revenue by Application (2023-2028) & (USD Million)

Table 93. Middle East & Africa Influenza Diagnostics Revenue by Country (2017-2022) & (USD Million)

Table 94. Middle East & Africa Influenza Diagnostics Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Influenza Diagnostics Picture

Figure 2. Global Influenza Diagnostics Revenue Market Share by Type in 2021

Figure 3. RIDT

Figure 4. RT-PCR

Figure 5. Cell Culture

Figure 6. Others

Figure 7. Influenza Diagnostics Revenue Market Share by Application in 2021

Figure 8. Hospitals Picture

Figure 9. POCT Picture

Figure 10. Others Picture

Figure 11. Global Influenza Diagnostics Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 12. Global Influenza Diagnostics Revenue and Forecast (2017-2028) & (USD Million)

Figure 13. Global Influenza Diagnostics Revenue Market Share by Region (2017-2028)

Figure 14. Global Influenza Diagnostics Revenue Market Share by Region in 2021

Figure 15. North America Influenza Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Europe Influenza Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Asia-Pacific Influenza Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. South America Influenza Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Middle East and Africa Influenza Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Influenza Diagnostics Market Drivers

Figure 21. Influenza Diagnostics Market Restraints

Figure 22. Influenza Diagnostics Market Trends

Figure 23. BD Recent Developments and Future Plans

Figure 24. Abbott (Include Alere) Recent Developments and Future Plans

Figure 25. Roche Recent Developments and Future Plans

Figure 26. SIEMENS Recent Developments and Future Plans

Figure 27. Analytik Jena Recent Developments and Future Plans

Figure 28. Quidel Recent Developments and Future Plans

Figure 29. Thermo Fisher Recent Developments and Future Plans

Figure 30. Meridian Bioscience Recent Developments and Future Plans

Figure 31. BioMerieux Recent Developments and Future Plans

Figure 32. Sekisui Diagnostics Recent Developments and Future Plans

Figure 33. Response Biomedical Recent Developments and Future Plans

Figure 34. SA Scientific Recent Developments and Future Plans

Figure 35. Global Influenza Diagnostics Revenue Share by Players in 2021

Figure 36. Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 37. Global Top 3 Players Influenza Diagnostics Revenue Market Share in 2021

Figure 38. Global Top 10 Players Influenza Diagnostics Revenue Market Share in 2021

Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 40. Global Influenza Diagnostics Revenue Share by Type in 2021

Figure 41. Global Influenza Diagnostics Market Share Forecast by Type (2023-2028)

Figure 42. Global Influenza Diagnostics Revenue Share by Application in 2021

Figure 43. Global Influenza Diagnostics Market Share Forecast by Application (2023-2028)

Figure 44. North America Influenza Diagnostics Sales Market Share by Type (2017-2028)

Figure 45. North America Influenza Diagnostics Sales Market Share by Application (2017-2028)

Figure 46. North America Influenza Diagnostics Revenue Market Share by Country (2017-2028)

Figure 47. United States Influenza Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Canada Influenza Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Mexico Influenza Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Europe Influenza Diagnostics Sales Market Share by Type (2017-2028)

Figure 51. Europe Influenza Diagnostics Sales Market Share by Application (2017-2028)

Figure 52. Europe Influenza Diagnostics Revenue Market Share by Country (2017-2028)

Figure 53. Germany Influenza Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. France Influenza Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. United Kingdom Influenza Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Russia Influenza Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Italy Influenza Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Asia-Pacific Influenza Diagnostics Sales Market Share by Type (2017-2028)

Figure 59. Asia-Pacific Influenza Diagnostics Sales Market Share by Application (2017-2028)

Figure 60. Asia-Pacific Influenza Diagnostics Revenue Market Share by Region (2017-2028)

Figure 61. China Influenza Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Japan Influenza Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. South Korea Influenza Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. India Influenza Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Southeast Asia Influenza Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Australia Influenza Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. South America Influenza Diagnostics Sales Market Share by Type (2017-2028)

Figure 68. South America Influenza Diagnostics Sales Market Share by Application (2017-2028)

Figure 69. South America Influenza Diagnostics Revenue Market Share by Country (2017-2028)

Figure 70. Brazil Influenza Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Argentina Influenza Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Middle East and Africa Influenza Diagnostics Sales Market Share by Type (2017-2028)

Figure 73. Middle East and Africa Influenza Diagnostics Sales Market Share by Application (2017-2028)

Figure 74. Middle East and Africa Influenza Diagnostics Revenue Market Share by Country (2017-2028)

Figure 75. Turkey Influenza Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Saudi Arabia Influenza Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. UAE Influenza Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Methodology

Figure 79. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz